Close
Show
Home Drug Research

Drug Research

This Drug Research section covers latest in Pharma drug research updates & Pharmaceutical drug research news & Pharma industry research and developments.

I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms

RVAC Medicines and A*STAR to Build Capabilities for mRNA Production in Singapore


RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a...

Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity


Merck, a leading science and technology company, invests more than € 290 million in its...
BioInvent extends research collaboration and license agreement with Pfizer Inc

Quadripartite launches a new platform to tackle antimicrobial resistance threat to human and animal...


The Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched to ensure the growing threats and impacts...

Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics...


Regeneron Pharmaceuticals, Inc.  and CytomX Therapeutics, Inc.  announced a collaboration and licensing agreement to create...

Australia Offers A Nasal Vaccine To Guard Against COVID-19


Researchers from Australia's Centenary Institute and the University of Sydney have created a novel nasal...

Big Pharma May Need To Report State Deals In WHO Crisis


Under new regulations that would oversee a pandemic agreement approved by the World Health Organization,...

In Britain, The ABPI Sets Out A Clear Antimicrobial Goal


The Association of the British Pharmaceutical Industry (ABPI) has reemphasized its message to the industry...

First Implanted Pump Uses Chemotherapy To Treat Brain Cancer


In a Phase I study that was recently published in the journal Lancet Oncology, it...
WHO

IGBA- 2022 WHO Biosimilar Roadmap Facilitates Accessibility


According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars...

GHIT Fund Invests ¥790M On Neglected Tropical Disease Items


Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about...